Lethal Prostate Cancer Risk Appears Potentially Reduced by Regular Aspirin Intake

Lethal Prostate Cancer Risk Appears Potentially Reduced by Regular Aspirin Intake
Regular aspirin use in men with prostate cancer is potentially associated with a reduced risk of prostate cancer-specific deaths, according to a study presented at the 2016 Genitourinary Cancers Symposium in San Francisco. The study,  "Regular aspirin use and the risk of lethal prostate cancer in the Physicians' Health study," is available at the meeting’s website. Several studies have reported the preventive effects of aspirin against many diseases, such as cardiovascular disease. Such suggested benefits have also been reported for prostate cancer, with several reports hinting at an inverse correlation between aspirin use and advanced prostate cancer. But potential effects on lethal prostate cancer had not yet been investigated until now. Researchers evaluated data from 22,071 male patients who enrolled in the Physicians' Health study from 1982 to 2009 to assess the association between regular aspirin intake (defined as more than three tablets per week) and lethal prostate cancer, manifested as metastases or prostate cancer death. Secondary outcomes included the incidence of total, high-grade and advanced cancers. Results show that, among the 3,193 men diagnosed with prostate cancer during the 27 years of follow-up, patients who regularly took aspirin after diagnosis had a 39 percent reduced risk of death from the cancer. Moreover, men without prostate cancer at the time they enrolled in the study and who took aspirin regularly had a 24 percent lower risk for lethal prostate cancer, although their risk for developing any sort of prostate cancer was not affected. Researchers say the link between t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *